Top Markets
Coin of the day
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Classement en actions #28218
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Prix de l'action
$0.4
Dernière synchronisation: 2026-10-02
Capitalisation boursière
$27.18M
Changement (1 jour)
-14.88%
Changement (1 an)
8.11%
Pays
US
Échange Cell Source, Inc. (CLCS)

Catégorie

Historique des divisions d’actions pour Cell Source, Inc. (CLCS)
L’action Cell Source, Inc. (symbole : CLCS) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 06, 2026.
Une action CLCS achetée avant le Oct 06, 2026 équivaudrait aujourd’hui à 0 actions CLCS.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH